Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02037802
Other study ID # SMS2014-1
Secondary ID
Status Completed
Phase N/A
First received January 14, 2014
Last updated October 2, 2014
Start date March 2014
Est. completion date October 2014

Study information

Verified date October 2014
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority Egypt:Cairo university
Study type Interventional

Clinical Trial Summary

pain control in pediatric renal transplant is a major concern. the main goal during anesthesia of renal transplant in pediatrics is to maintain hemodynamics in a range close to that of the adult donor. epidural analgesia is thought to be very effective in pain control. this study emphasises the ease of application of epidural catheter via the caudal route to the lower thoracic level; avoiding possible complications that may arise from lumbar or thoracic routes, and its effects on hemodynamics when using analgesic doses of local anesthetics and narcotics.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 2014
Est. primary completion date October 2014
Accepts healthy volunteers No
Gender Both
Age group 3 Years to 12 Years
Eligibility Inclusion Criteria:

- 3-12 years

- end stage renal disease

- no known allergy to bupivacaine

- both sexes

Exclusion Criteria:

- known allergy to bupivacaine

- inflammation at caudal area

- spinal cord deformity

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Device:
B-Braun, Perifix® ONE Paed, Germany
caudal epidural catheterization bupivacaine fentanyl
Drug:
Pethidine
pethidine intravenous at a dose 1mg/kg when pain score more than 5 postoperative rescue analgesia
Propofol
fentanyl propofol atracurium besylate
Bupivacaine

Fentanyl


Locations

Country Name City State
Egypt Faculty of medicine, Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Other pain scoring system (objective behavioural pain score) from the time of transfere to the nephrology ICU, every hour for the first 24 hours postoperative No
Primary Intraoperative blood pressure measure systolic and diastolic blood pressure from the induction of anesthesia till end of surgery at half an hour intervals No
Secondary postoperative blood pressure record systolic and diastolic blood pressure every hour for the first 24 hours postoperative from the time of transfer of the patient to the intensive care unit at one hour intervals for 24 hours No
Secondary intraoperative central venous pressure fromom the induction of anesthesia till end of surgery at half an hour intervals No
Secondary postoperative heart rate from the time of transfer of the patient to the intensive care unit at one hour intervals for 24 hours No
Secondary postoperative central venous pressure from the time of transfer of the patient to the intensive care unit at one hour intervals for 24 hours No
Secondary intraoperative heart rate from the induction of anesthesia till end of surgery at half an hour intervals No
See also
  Status Clinical Trial Phase
Completed NCT02763410 - Impact of the Composition of Packed Red Blood Cell Supernatant on Renal Dysfunction and Posttransfusion Immunomodulation
Active, not recruiting NCT03183245 - Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Phase 3
Completed NCT04084301 - Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury N/A
Completed NCT03292029 - Pilot Medical Evaluation of the T50 Test N/A
Suspended NCT04589065 - SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device) N/A
Completed NCT03806998 - Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure Phase 3
Active, not recruiting NCT03672110 - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Phase 3
Completed NCT02325726 - RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery. N/A
Completed NCT02116270 - Accelerated Immunosenescence and Chronic Kidney Disease N/A
Completed NCT01388270 - Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis Phase 4
Completed NCT01859273 - Adherence Enhancement for Renal Transplant Patients N/A
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT00966615 - The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition Phase 4
Completed NCT01187953 - Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacroâ„¢ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx Phase 3
Completed NCT01008631 - The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers N/A
Completed NCT00765661 - Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients Phase 2
Completed NCT00737672 - GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis Phase 3
Completed NCT00808691 - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit N/A
Recruiting NCT00470769 - The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR N/A
Terminated NCT00338455 - Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC Phase 2